Printer Friendly

Joy at breast cancer breakthrough.

RESEARCHERS were so excited by early results from a study on preventing the recurrence of breast cancer they halted their work so more women could benefit from the findings.

The study, published online by the New England Journal of Medicine, showed breast cancer patients who followed up five years of tamoxifen treatment with letrozole, an oestrogen suppresser, cut the risk of recurrence by nearly half. Doctors involved in the study said the findings could benefit hundreds of thousands of women.
COPYRIGHT 2003 Coventry Newpapers
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Coventry Evening Telegraph (England)
Date:Oct 10, 2003
Words:80
Previous Article:Jackie crowned Miss England.
Next Article:Tribute 'not a victory parade'.


Related Articles
I'm a fighter, says cancer shock star.
DRUG HOPE FOR CANCER.
Cancer deaths cut by new drug.
Wear the pink with lots of pride.
Charlie's No.10 visit for study; HONOUR: Delight at breast cancer scheme talks with PM's wife.
'Wonder drug' a true cancer-buster.
Study finds breast cancer changes with spread.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |